PCM
CSCI

Prelude Capital Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Prelude Capital Management’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Hold
0
– – – 2322
2020
Q3 		– Hold
0
– – – 2683
2017
Q4 		– Sell
-107
Closed -$22K – 1832
2017
Q3 		$22K Buy
107
+97
+970% +$17.9K ﹤0.01% 1301
2017
Q2 		$1K Buy
+10
New +$1.58K ﹤0.01% 1556
2017
Q1 		– Sell
-4
Closed -$1K – 1857
2016
Q4 		$1K Sell
4
-13
-76% -$4.84K ﹤0.01% 1502
2016
Q3 		$6K Buy
+17
New +$5.96K ﹤0.01% 1480
2016
Q1 		– Sell
-4
Closed -$2K – 1596
2015
Q4 		$2K Buy
+4
New +$2.51K ﹤0.01% 1404

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
RFA
Reilly Financial Advisors La Mesa, California $1.35B AUM 22.65% 1-Year Est. Return
DWM
Dorchester Wealth Management Montreal, Quebec, Canada $501M AUM 16.39% 1-Year Est. Return